Cargando…
Aberrant lactate dehydrogenase A signaling contributes metabolic signatures in pancreatic cancer
BACKGROUND: Pancreatic cancer (PC) has the lowest 5-year survival rate; therefore, new early screening methods and therapeutic targets are still urgently required. Emerging technologies such as metabolomic-based liquid biopsy may contribute to the field. We found aberrant lactate dehydrogenase A (LD...
Autores principales: | Jiang, Wenna, Qiao, Lu, Zuo, Duo, Qin, Di, Xiao, Jiawei, An, Haohua, Wang, Yanhui, Zhang, Xinwei, Jin, Yu, Ren, Li |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7944301/ https://www.ncbi.nlm.nih.gov/pubmed/33708985 http://dx.doi.org/10.21037/atm-21-295 |
Ejemplares similares
-
Pancreatic stellate cells regulate branched-chain amino acid metabolism in pancreatic cancer
por: Jiang, Wenna, et al.
Publicado: (2021) -
Loss of BCAA catabolism enhances Rab1A-mTORC1 signaling activity and promotes tumor proliferation in NSCLC
por: Xue, Meiting, et al.
Publicado: (2023) -
BCKDK alters the metabolism of non-small cell lung cancer
por: Wang, Yanhui, et al.
Publicado: (2021) -
Prognostic relevance of lactate dehydrogenase in advanced pancreatic ductal adenocarcinoma patients
por: Xiao, Yuanyuan, et al.
Publicado: (2017) -
The Application Value of Lipoprotein Particle Numbers in the Diagnosis of HBV-Related Hepatocellular Carcinoma with BCLC Stage 0-A
por: Zuo, Duo, et al.
Publicado: (2021)